Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-30

Clinical Trial Update: Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of unrelated umbilical cord blood microtransplantation in patients with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • unrelated umbilical cord blood microtransplantation

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Acute Myelocytic Leukemia | Phase 2 | Status: UNKNOWN